SEPTIN7P9: Key Component of The Blood-Brain Barrier and Potential Drug Target
SEPTIN7P9: Key Component of The Blood-Brain Barrier and Potential Drug Target
SEPTIN7P9 (bA291L22.2) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a key component of the sepin family, which is a family of transmembrane proteins that play a critical role in cell signaling and structure. SEPTIN7P9 is unique because it is a type of sepin that is expressed in the brain, where it is involved in the formation and maintenance of the blood-brain barrier.
The blood-brain barrier is a critical barrier that separates the brain from the rest of the body. It is designed to protect the brain from harmful substances and to allow only certain types of substances to come into the brain. The blood-brain barrier is formed by a layer of endothelial cells, which are specialized cells that line the blood vessels in the brain. These endothelial cells produce a protein called tight junction protein (TJP), which is a key component of the blood-brain barrier.
SEPTIN7P9 is involved in the formation and maintenance of the blood-brain barrier by helping to regulate the production of TJP. TJP is produced by endothelial cells, and it is important for maintaining the tightness of the blood-brain barrier. The blood-brain barrier is critical for the health and function of the brain, and it is thought to play a role in the development of many neurological and psychiatric disorders.
SEPTIN7P9 is also involved in the regulation of other processes in the brain, including the formation of new blood vessels, the regulation of ion channels, and the production of neurotransmitters. It is also involved in the regulation of the blood-brain barrier in response to changes in the levels of certain chemicals in the brain, such as neurotransmitters.
SEPTIN7P9 is a unique protein because it is expressed in the brain and is involved in the formation and maintenance of the blood-brain barrier. It is also involved in the regulation of other processes in the brain, including the formation of new blood vessels, the regulation of ion channels, and the production of neurotransmitters. These properties make SEPTIN7P9 an attractive drug target, and it is a potential target for the development of new treatments for a variety of neurological and psychiatric disorders.
Protein Name: Septin 7 Pseudogene 9
More Common Targets
SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3 | SESTD1 | Sestrin | SET | SET1 histone methyltransferase complex | SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3 | SETD4 | SETD4-AS1 | SETD5 | SETD6 | SETD7 | SETD9 | SETDB1 | SETDB2 | SETMAR | SETP14 | SETP20 | SETP22 | SETX | SEZ6 | SEZ6L | SEZ6L2 | SF1 | SF3A1